AAK1 and infection: They identified AAK1 as a crucial component for RABV entry into host cells through an RNA interference approach, and knocking down AAK1 limited the phosphorylation of AP-2 and decreased RABV infection in vitro. Moreover, sunitinib treatment reduced AP-2 phosphorylation and prevented RABV from entering the early endosomes.